relcovaptan has been researched along with Brain Hemorrhage, Cerebral, Traumatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fathali, N; Hasegawa, Y; Khatibi, NH; Lekic, T; Manaenko, A; Martin, R; Tang, J; Zhang, JH | 1 |
1 other study(ies) available for relcovaptan and Brain Hemorrhage, Cerebral, Traumatic
Article | Year |
---|---|
Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Behavior, Animal; Blood Gas Analysis; Blood Pressure; Brain Edema; Cerebral Hemorrhage, Traumatic; Dose-Response Relationship, Drug; Indoles; Male; Mice; Neuropsychological Tests; Oligopeptides; Pyrrolidines; Pyrrolidonecarboxylic Acid | 2011 |